摘要
目的 :探讨米索前列醇加利凡诺羊膜腔注射对中期妊娠引产的临床疗效和安全性。方法 :将212例妊娠12～28周的孕妇随机分成两组 ,单纯用利凡诺羊膜腔内注射引产为对照组 ,利凡诺羊膜腔内注射后阴道后穹窿米索前列醇置入为观察组 ,观察两组引产效果。结果 :观察组产程缩短 ,胎盘残留率及清宫率比对照组明显降低 (P<0 01)。结论 :米索前列醇加利凡诺羊膜腔内注射用于中期妊娠引产时间短 ,产后出血少 ,且能减少宫腔操作及住院天数 ,有临床应用价值。
Objective:To study the clinical effect and safety of amniotic cavity injection of misoprofil plus rivanol in metaphase induced laˉbor.Methods:212cases of gravida for12to28weeks were divided into control group and observation group.The former was treated only with rivanol by amniotic cavity injection,besides that,the later was added misoprofil by placing in posterior vault of vagina.The clinical effect of induced labor between themwas observed and compared.Results:In the observation group,the labor process was short and the residual rate of placenta was lowcompared with those in the control group(P<0.01).Conclusion:The application of amniotic cavity injection of misoprofil plus vivanol for metaphase induced labor can shorten the birth process,decrease hemorrhage and intra-uterus procedure and shorten hospitalization days.Thus it possesses a clinical applied value.
出处
《现代医药卫生》
2004年第18期1843-1844,共2页
Journal of Modern Medicine & Health
